Susquehanna International Group
XBI icon

Susquehanna International Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Susquehanna International Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$660M Sell
5,165,500
-3,098,100
-37% -$387M 0.07% 213
2025
Q4 		$1.01B Buy
8,263,600
+5,168,600
+167% +$593M 0.12% 127
2025
Q3 		$310M Sell
3,095,000
-864,300
-22% -$77.8M 0.04% 401
2025
Q2 		$328M Buy
3,959,300
+2,024,500
+105% +$162M 0.05% 312
2025
Q1 		$157M Sell
1,934,800
-637,000
-25% -$56.9M 0.03% 470
2024
Q4 		$232M Sell
2,571,800
-448,300
-15% -$43.4M 0.04% 380
2024
Q3 		$298M Buy
3,020,100
+1,943,200
+180% +$191M 0.05% 289
2024
Q2 		$99.8M Sell
1,076,900
-4,538,400
-81% -$407M 0.02% 603
2024
Q1 		$533M Buy
5,615,300
+9,100
+0.2% +$844K 0.09% 166
2023
Q4 		$501M Buy
5,606,200
+2,005,000
+56% +$149M 0.1% 168
2023
Q3 		$263M Sell
3,601,200
-769,300
-18% -$61.5M 0.05% 267
2023
Q2 		$364M Buy
4,370,500
+891,600
+26% +$74.6M 0.07% 196
2023
Q1 		$265M Sell
3,478,900
-1,660,500
-32% -$138M 0.06% 274
2022
Q4 		$427M Sell
5,139,400
-788,200
-13% -$63.8M 0.11% 153
2022
Q3 		$470M Buy
5,927,600
+1,835,200
+45% +$155M 0.12% 125
2022
Q2 		$306M Sell
4,092,400
-6,600
-0.2% -$495K 0.08% 198
2022
Q1 		$372M Buy
4,099,000
+589,800
+17% +$54.5M 0.06% 222
2021
Q4 		$397M Buy
3,509,200
+1,972,700
+128% +$238M 0.06% 265
2021
Q3 		$193M Sell
1,536,500
-938,900
-38% -$121M 0.03% 530
2021
Q2 		$336M Sell
2,475,400
-213,300
-8% -$28M 0.05% 324
2021
Q1 		$365M Buy
2,688,700
+73,100
+3% +$10.9M 0.06% 278
2020
Q4 		$377M Buy
2,615,600
+128,700
+5% +$16.5M 0.06% 237
2020
Q3 		$278M Buy
2,486,900
+311,600
+14% +$34.9M 0.05% 265
2020
Q2 		$244M Buy
2,175,300
+1,045,300
+93% +$103M 0.06% 260
2020
Q1 		$88.2M Sell
1,130,000
-1,417,800
-56% -$126M 0.03% 435
2019
Q4 		$242M Sell
2,547,800
-306,800
-11% -$26.5M 0.07% 231
2019
Q3 		$218M Buy
2,854,600
+991,400
+53% +$82.4M 0.07% 226
2019
Q2 		$163M Sell
1,863,200
-442,400
-19% -$37.7M 0.06% 270
2019
Q1 		$209M Sell
2,305,600
-327,900
-12% -$27.9M 0.09% 190
2018
Q4 		$189M Buy
2,633,500
+164,000
+7% +$13.2M 0.08% 225
2018
Q3 		$237M Buy
2,469,500
+924,300
+60% +$89.6M 0.08% 212
2018
Q2 		$147M Sell
1,545,200
-860,900
-36% -$79.1M 0.05% 305
2018
Q1 		$211M Buy
2,406,100
+683,500
+40% +$62.4M 0.08% 212
2017
Q4 		$146M Sell
1,722,600
-1,085,200
-39% -$90.9M 0.05% 309
2017
Q3 		$243M Sell
2,807,800
-627,400
-18% -$50.3M 0.09% 180
2017
Q2 		$265M Buy
3,435,200
+423,500
+14% +$30M 0.12% 144
2017
Q1 		$209M Sell
3,011,700
-1,517,000
-33% -$102M 0.11% 163
2016
Q4 		$268M Sell
4,528,700
-157,300
-3% -$9.71M 0.14% 121
2016
Q3 		$311M Buy
4,686,000
+740,900
+19% +$45.8M 0.15% 101
2016
Q2 		$213M Sell
3,945,100
-810,300
-17% -$44.4M 0.11% 142
2016
Q1 		$246M Buy
4,755,400
+2,216,600
+87% +$115M 0.13% 114
2015
Q4 		$178M Sell
2,538,800
-1,438,700
-36% -$98.1M 0.08% 204
2015
Q3 		$248M Buy
3,977,500
+57,100
+1% +$4.5M 0.11% 157
2015
Q2 		$330M Buy
3,920,400
+1,578,900
+67% +$123M 0.14% 111
2015
Q1 		$176M Buy
2,341,500
+1,607,700
+219% +$112M 0.08% 225
2014
Q4 		$45.7M Buy
733,800
+15,600
+2% +$889K 0.02% 774
2014
Q3 		$37.3M Buy
718,200
+550,200
+328% +$28.1M 0.01% 914
2014
Q2 		$8.63M Sell
168,000
-2,510,700
-94% -$113M ﹤0.01% 2285
2014
Q1 		$127M Buy
2,678,700
+2,188,800
+447% +$112M 0.06% 285
2013
Q4 		$21.3M Buy
489,900
+439,200
+866% +$18.2M 0.01% 1290
2013
Q3 		$2.18M Sell
50,700
-453,600
-90% -$18.4M ﹤0.01% 3958
2013
Q2 		$17.5M Buy
+504,300
New +$17.7M 0.01% 1229

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's XBI Position: Q1 2026 in Review

Susquehanna International Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 80% in Q1 2026, selling an estimated $36.7M and leaving 74,189 shares worth $9.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

Susquehanna International Group first reported a position in XBI in Q2 2013 and has held it in 50 quarters since. The position peaked at $284M in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Susquehanna International Group held 74,189 shares of State Street SPDR S&P Biotech ETF worth $9.48M as of Q1 2026.
  • Susquehanna International Group sold 293,721 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $36.7M.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3193 holding.
  • Susquehanna International Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's State Street SPDR S&P Biotech ETF position peaked at $284M in Q4 2020.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.